Efficacy of Topical Calcipotriol-assisted Ablative Fractional Laser Photodynamic Therapy for the Treatment of Actinic Keratosis: 12-month Follow-up Results of a Prospective, Randomised, Comparative Trial

Trial Profile

Efficacy of Topical Calcipotriol-assisted Ablative Fractional Laser Photodynamic Therapy for the Treatment of Actinic Keratosis: 12-month Follow-up Results of a Prospective, Randomised, Comparative Trial

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Nov 2017

At a glance

  • Drugs Calcipotriol (Primary) ; Lidocaine/prilocaine; Methyl aminolevulinate
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Nov 2017 Primary endpoint (Difference of the recurrence rates between VitD-AFL-PDT and AFL-PDT) has been met as per the results published in the Journal of the American Academy of Dermatology
    • 11 Nov 2017 Primary endpoint (Differences of long-term complete response rates between VitD-AFL-PDT and AFL-PDT) has been met as per the results published in the Journal of the American Academy of Dermatology
    • 11 Nov 2017 Primary endpoint (Differences of short-term complete response rates between VitD-AFL-PDT and AFL-PDT) has not been met as per the results published in the Journal of the American Academy of Dermatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top